604 related articles for article (PubMed ID: 17656049)
1. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis pilin-Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
Angelos JA; Bonifacio RG; Ball LM; Hess JF
Vet Microbiol; 2007 Dec; 125(3-4):274-83. PubMed ID: 17656049
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
Angelos JA; Gohary KG; Ball LM; Hess JF
Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
[TBL] [Abstract][Full Text] [Related]
3. Prevention of naturally occurring infectious bovine keratoconjunctivitis with a recombinant Moraxella bovis cytotoxin-ISCOM matrix adjuvanted vaccine.
Angelos JA; Hess JF; George LW
Vaccine; 2004 Dec; 23(4):537-45. PubMed ID: 15530703
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Moraxella bovoculi cytotoxin-ISCOM matrix adjuvanted vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
Angelos JA; Lane VM; Ball LM; Hess JF
Vet Res Commun; 2010 Mar; 34(3):229-39. PubMed ID: 20217228
[TBL] [Abstract][Full Text] [Related]
5. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
McConnel CS; Shum L; Gleeson BL; House JK
Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
[TBL] [Abstract][Full Text] [Related]
6. A randomized and blinded field trial to assess the efficacy of an autogenous vaccine to prevent naturally occurring infectious bovine keratoconjunctivis (IBK) in beef calves.
Funk L; O'Connor AM; Maroney M; Engelken T; Cooper VL; Kinyon J; Plummer P
Vaccine; 2009 Jul; 27(34):4585-90. PubMed ID: 19531391
[TBL] [Abstract][Full Text] [Related]
7. Systemic and ocular immune responses in cattle following intranasal vaccination with precipitated or partially solubilized recombinant Moraxella bovis cytotoxin adjuvanted with polyacrylic acid.
Angelos JA; Chigerwe M; Edman JM; Hess JF
Am J Vet Res; 2016 Dec; 77(12):1411-1418. PubMed ID: 27901388
[TBL] [Abstract][Full Text] [Related]
8. Descriptive epidemiology of Moraxella bovis, Moraxella bovoculi and Moraxella ovis in beef calves with naturally occurring infectious bovine keratoconjunctivitis (Pinkeye).
O'Connor AM; Shen HG; Wang C; Opriessnig T
Vet Microbiol; 2012 Mar; 155(2-4):374-80. PubMed ID: 21962410
[TBL] [Abstract][Full Text] [Related]
9. Relatedness of type IV pilin PilA amongst geographically diverse
Angelos JA; Clothier KA; Agulto RL; Mandzyuk B; Tryland M
J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33404383
[No Abstract] [Full Text] [Related]
10. Infectious bovine keratoconjunctivitis in cattle vaccinated and medicated against Moraxella bovis before parturition.
Pugh GW; Kopecky KE; Kvasnicka WG; McDonald TJ; Booth GD
Am J Vet Res; 1982 Feb; 43(2):320-5. PubMed ID: 7091830
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial evaluating a farm-of-origin autogenous Moraxella bovis vaccine to control infectious bovine keratoconjunctivis (pinkeye) in beef cattle.
O'Connor AM; Brace S; Gould S; Dewell R; Engelken T
J Vet Intern Med; 2011; 25(6):1447-53. PubMed ID: 22092641
[TBL] [Abstract][Full Text] [Related]
12. Relatedness of cytotoxins from geographically diverse isolates of Moraxella bovis.
Angelos JA; Ball LM
Vet Microbiol; 2007 Oct; 124(3-4):382-6. PubMed ID: 17540518
[TBL] [Abstract][Full Text] [Related]
13. Infectious bovine keratoconjunctivitis: effects of vaccination on Moraxella bovis carrier state in cattle.
Pugh GW; McDonald TJ; Kopecky KE
Am J Vet Res; 1980 Feb; 41(2):264-6. PubMed ID: 7369598
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis.
George LW; Borrowman AJ; Angelos JA
Am J Vet Res; 2005 Jan; 66(1):136-42. PubMed ID: 15691049
[TBL] [Abstract][Full Text] [Related]
15. Randomized blinded controlled trial to assess the association between a commercial vaccine against Moraxella bovis and the cumulative incidence of infectious bovine keratoconjunctivitis in beef calves.
Cullen JN; Engelken TJ; Cooper V; O'Connor AM
J Am Vet Med Assoc; 2017 Aug; 251(3):345-351. PubMed ID: 28703672
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytokines as adjuvants of infectious bovine keratoconjunctivitis vaccines.
di Girolamo FA; Sabatini DJ; Fasan RA; Echegoyen M; Vela M; Pereira CA; Maure P
Vet Immunol Immunopathol; 2012 Jan; 145(1-2):563-6. PubMed ID: 22264735
[TBL] [Abstract][Full Text] [Related]
17. Bacteriologic and vaccination studies in a field epizootic of infectious bovine keratoconjunctivitis in calves.
Arora AK; Killinger AH; Mansfield ME
Am J Vet Res; 1976 Jul; 37(7):803-5. PubMed ID: 937804
[TBL] [Abstract][Full Text] [Related]
18. Infection rates, disease frequency, pilin gene rearrangement, and pilin expression in calves inoculated with Moraxella bovis pilin-specific isogenic variants.
Ruehl WW; Marrs CF; George L; Banks SJ; Schoolnik GK
Am J Vet Res; 1993 Feb; 54(2):248-53. PubMed ID: 8094276
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tulathromycin for treatment of cattle with acute ocular Moraxella bovis infections.
Lane VM; George LW; Cleaver DM
J Am Vet Med Assoc; 2006 Aug; 229(4):557-61. PubMed ID: 16910856
[TBL] [Abstract][Full Text] [Related]
20. A Moraxella bovis pili vaccine produced by recombinant DNA technology for the prevention of infectious bovine keratoconjunctivitis.
Lepper AW; Elleman TC; Hoyne PA; Lehrbach PR; Atwell JL; Schwartzkoff CL; Egerton JR; Tennent JM
Vet Microbiol; 1993 Jul; 36(1-2):175-83. PubMed ID: 7901935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
